Latest News

Check out what is happening at HCD Economics

October 2021

New CHESS study seeks research partners– CHESS will, for the first time, inform enhanced longitudinal understanding of the burden of illness for patients with haemophilia

Results from the first CHESS study were published in July 2017 (O’Hara et al. Orphanet Journal of Rare Diseases (2017) 12:106). The study investigated the burden of illness (BOI) for haemophilia patients and has been instrumental as a source of health economic evidence in advocating for access for these patients to new genetic advances in treatment.
Continue Reading
October 2021

‘Socioeconomic evidence – a human aspect that science alone lacks’

‘Socioeconomic evidence – a human aspect that science alone lacks’ Tara Kearns (Vice President and Co-Founder, PFIC* Advocacy and Resource Network) ‘research is absolutely where my passion lies, as I know this will create the most change!’ Melanie Karakaidos (Director of Global Advocacy and Outreach, PFIC* Advocacy and Resource Network)
Continue Reading
September 2021

Preference Research – new Haemophilia study published

As a timely follow up to our June 2021 news article by George Morgan, ‘Preference research – the evidence based approach to quantifying the patient voice’, HCD Economics is able to report publication of a new preference research study, undertaken by George and co-authors, under the lead authorship of Michelle Witkop, Head of Research at the United States National Hemophilia Foundation. The study is published in Haemophilia, the official journal of the World Federation of Hemophilia.
Continue Reading
Scroll for more

About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.

Charities

Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.

Data

We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more
Scroll for more